Trial Outcomes & Findings for Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder (NCT NCT00118911)

NCT ID: NCT00118911

Last Updated: 2018-01-02

Results Overview

ADHD symptom severity as measured by the ADHD rating scale (DuPaul, et al., 1998) a scale that ranges from 0-54 with 0 indicating lower severity.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

86 participants

Primary outcome timeframe

post-treatment (after receiving 12 sessions of treatment)

Results posted on

2018-01-02

Participant Flow

Subjects were recruited via clinics associated with Massachusetts General Hospital, local radio advertisements, advertisements posted throughout the hospital, as well as through referrals from other mental health professionals. The study was conducted between November, 2004 and June, 2008 (follow-up was conducted through July, 2009).

A total of 138 individuals were consented and assessed for eligibility. Of these, 52 individuals were excluded prior to randomization (36 didn't meet inclusion criteria, 8 declined to participate, 6 were excluded for unknown reasons, and 2 were excluded for other reasons).

Participant milestones

Participant milestones
Measure
Cognitive-Behavioral Therapy (CBT)
Participants received 12 sessions of individual cognitive behavioral therapy following our protocol.
Relaxation With Educational Support (RES)
Participants received 12 sessions of individual therapy using our unpublished treatment manual for relaxation plus educational support.
Overall Study
STARTED
43
43
Overall Study
Received Intervention as Assigned
41
38
Overall Study
Completed Post-Treatment Assessment
41
37
Overall Study
6 Month Follow-up
37
30
Overall Study
12 Month Follow-up
38
32
Overall Study
COMPLETED
41
38
Overall Study
NOT COMPLETED
2
5

Reasons for withdrawal

Reasons for withdrawal
Measure
Cognitive-Behavioral Therapy (CBT)
Participants received 12 sessions of individual cognitive behavioral therapy following our protocol.
Relaxation With Educational Support (RES)
Participants received 12 sessions of individual therapy using our unpublished treatment manual for relaxation plus educational support.
Overall Study
Withdrawal by Subject
2
5

Baseline Characteristics

Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cognitive-Behavioral Therapy (CBT)
n=43 Participants
Participants received 12 sessions of individual cognitive behavioral therapy following our protocol.
Relaxation With Educational Support (RES)
n=43 Participants
Participants received 12 sessions of individual therapy using our unpublished treatment manual for relaxation plus educational support.
Total
n=86 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
43 Participants
n=5 Participants
43 Participants
n=7 Participants
86 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
42.3 years
STANDARD_DEVIATION 10.3 • n=5 Participants
44 years
STANDARD_DEVIATION 12.2 • n=7 Participants
43.15 years
STANDARD_DEVIATION 11.25 • n=5 Participants
Sex: Female, Male
Female
19 Participants
n=5 Participants
19 Participants
n=7 Participants
38 Participants
n=5 Participants
Sex: Female, Male
Male
24 Participants
n=5 Participants
24 Participants
n=7 Participants
48 Participants
n=5 Participants
Region of Enrollment
United States
43 participants
n=5 Participants
43 participants
n=7 Participants
86 participants
n=5 Participants

PRIMARY outcome

Timeframe: post-treatment (after receiving 12 sessions of treatment)

Population: Analysis was based on intent to treat. We used mixed-effect modeling which automatically imputes data using the slope up to the point of discontinuation.

ADHD symptom severity as measured by the ADHD rating scale (DuPaul, et al., 1998) a scale that ranges from 0-54 with 0 indicating lower severity.

Outcome measures

Outcome measures
Measure
Cognitive-Behavioral Therapy (CBT)
n=43 Participants
Participants received 12 sessions of individual cognitive behavioral therapy following our protocol.
Relaxation With Educational Support (RES)
n=43 Participants
Participants received 12 sessions of individual therapy using our unpublished treatment manual for relaxation plus educational support.
Post-treatment ADHD Symptoms
14.46 units on a scale of symptom severity
Standard Deviation 8.46
19.19 units on a scale of symptom severity
Standard Deviation 9.71

SECONDARY outcome

Timeframe: 12 month follow-up (12 months after baseline assessment)

maintenance of gains in CBT condition for those who responded or partially responded as measured by the ADHD symptom severity as measured by the ADHD rating scale (DuPaul, et al., 1998) a scale that ranges from 0-54 with 0 indicating lower severity.

Outcome measures

Outcome measures
Measure
Cognitive-Behavioral Therapy (CBT)
n=43 Participants
Participants received 12 sessions of individual cognitive behavioral therapy following our protocol.
Relaxation With Educational Support (RES)
n=43 Participants
Participants received 12 sessions of individual therapy using our unpublished treatment manual for relaxation plus educational support.
Maintenance of Gains in CBT Condition
13.39 units on a scale of symptom severity
Standard Deviation 8.49
16.97 units on a scale of symptom severity
Standard Deviation 10.72

Adverse Events

Cognitive-Behavioral Therapy (CBT)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Relaxation With Educational Support (RES)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Susan Sprich, Ph.D.

Massachusetts General Hospital

Phone: 617-726-5991

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place